Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Revenue

In the year 2023, Rigel Pharmaceuticals had annual revenue of $116.88M, a decrease of -2.79%. Revenue in the quarter ending December 31, 2023 was $35.79M, a -30.20% decrease year-over-year.

• Revenue (ttm): $116.88M
• Revenue Growth: -2.79%
• P/S Ratio: 1.65
• Revenue / Employee: $795,116
• Employees: 147
• Market Cap: 192.92M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	116.88M	-3.36M	-2.79%
Dec 31, 2022	120.24M	-28.99M	-19.43%
Dec 31, 2021	149.24M	40.62M	37.39%
Dec 31, 2020	108.62M	49.33M	83.21%
Dec 31, 2019	59.29M	14.78M	33.20%
Dec 31, 2018	44.51M	40.03M	892.62%
Dec 31, 2017	4.48M	-15.90M	-78.00%
Dec 31, 2016	20.38M	-8.51M	-29.46%
Dec 31, 2015	28.90M	20.65M	250.24%
Dec 31, 2014	8.25M	1.10M	15.38%
Dec 31, 2013	7.15M	4.90M	217.78%
Dec 31, 2012	2.25M	-2.50M	-52.63%
Dec 31, 2011	4.75M	-120.25M	-96.20%
Dec 31, 2010	125.00M	124.25M	16,566.67%
Dec 31, 2009	750.00K	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	12.60M	-20.87M	-62.36%
Dec 31, 2006	33.47M	16.95M	102.55%
Dec 31, 2005	16.53M	11.79M	249.17%
Dec 31, 2004	4.73M	-6.32M	-57.19%
Dec 31, 2003	11.06M	-4.73M	-29.98%
Dec 31, 2002	15.79M	485.00K	3.17%
Dec 31, 2001	15.30M	2.09M	15.77%
Dec 31, 2000	13.22M	4.23M	47.13%
Dec 31, 1999	8.98M	8.96M	31,985.71%
Dec 31, 1998	28.00K	-	-
Dec 31, 1997	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.